Global Non-invasive DNA Prenatal Testing Supply, Demand and Key Producers, 2026-2032
The global Non-invasive DNA Prenatal Testing market size is expected to reach $ 1563 million by 2032, rising at a market growth of 10.9% CAGR during the forecast period (2026-2032).
Non-invasive DNA Prenatal Testing refers to a prenatal genetic assessment approach that analyzes fetal DNA signals present in a pregnant individual?s biological sample, most commonly a maternal blood sample, to estimate the risk of fetal genetic abnormalities without invasive sampling procedures. The method relies on laboratory analysis and computational interpretation of DNA fragments originating from the pregnancy, producing results that support clinical decision making about whether confirmatory diagnostic testing is needed and how to manage prenatal care. It is used as a screening tool rather than a definitive diagnosis, and its value depends on standardized sample handling, analytical accuracy, and responsible clinical interpretation within established prenatal counseling and follow-up workflows.
Non-invasive DNA Prenatal Testing is increasingly positioned as the default genetic risk assessment step in modern prenatal care because it offers a strong combination of patient safety, clinical utility, and operational scalability. From a research report perspective, market expansion is primarily driven by the continued shift from traditional screening toward DNA-based risk stratification, improving laboratory automation and bioinformatics, and broader clinical comfort with standardized reporting and follow-up pathways. Competitive differentiation is moving beyond basic aneuploidy screening toward performance in low fetal signal conditions, robust quality control, clear result interpretability for clinicians, and integrated service models that bundle pretest education and post-test counseling. At the same time, the market remains shaped by payer policy and regulation, which increasingly favor providers with strong clinical validation, transparent limitations, and consistent end-to-end execution across geographies and provider networks.
This report studies the global Non-invasive DNA Prenatal Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-invasive DNA Prenatal Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-invasive DNA Prenatal Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-invasive DNA Prenatal Testing total market, 2021-2032, (USD Million)
Global Non-invasive DNA Prenatal Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Non-invasive DNA Prenatal Testing total market, key domestic companies, and share, (USD Million)
Global Non-invasive DNA Prenatal Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Non-invasive DNA Prenatal Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global Non-invasive DNA Prenatal Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Non-invasive DNA Prenatal Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Myriad Genetics, GGA, Fulgent Genetics, BillionToOne, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Non-invasive DNA Prenatal Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-invasive DNA Prenatal Testing Market, By Region:
1. How big is the global Non-invasive DNA Prenatal Testing market?
2. What is the demand of the global Non-invasive DNA Prenatal Testing market?
3. What is the year over year growth of the global Non-invasive DNA Prenatal Testing market?
4. What is the total value of the global Non-invasive DNA Prenatal Testing market?
5. Who are the Major Players in the global Non-invasive DNA Prenatal Testing market?
6. What are the growth factors driving the market demand?
Non-invasive DNA Prenatal Testing refers to a prenatal genetic assessment approach that analyzes fetal DNA signals present in a pregnant individual?s biological sample, most commonly a maternal blood sample, to estimate the risk of fetal genetic abnormalities without invasive sampling procedures. The method relies on laboratory analysis and computational interpretation of DNA fragments originating from the pregnancy, producing results that support clinical decision making about whether confirmatory diagnostic testing is needed and how to manage prenatal care. It is used as a screening tool rather than a definitive diagnosis, and its value depends on standardized sample handling, analytical accuracy, and responsible clinical interpretation within established prenatal counseling and follow-up workflows.
Non-invasive DNA Prenatal Testing is increasingly positioned as the default genetic risk assessment step in modern prenatal care because it offers a strong combination of patient safety, clinical utility, and operational scalability. From a research report perspective, market expansion is primarily driven by the continued shift from traditional screening toward DNA-based risk stratification, improving laboratory automation and bioinformatics, and broader clinical comfort with standardized reporting and follow-up pathways. Competitive differentiation is moving beyond basic aneuploidy screening toward performance in low fetal signal conditions, robust quality control, clear result interpretability for clinicians, and integrated service models that bundle pretest education and post-test counseling. At the same time, the market remains shaped by payer policy and regulation, which increasingly favor providers with strong clinical validation, transparent limitations, and consistent end-to-end execution across geographies and provider networks.
This report studies the global Non-invasive DNA Prenatal Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-invasive DNA Prenatal Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-invasive DNA Prenatal Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-invasive DNA Prenatal Testing total market, 2021-2032, (USD Million)
Global Non-invasive DNA Prenatal Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Non-invasive DNA Prenatal Testing total market, key domestic companies, and share, (USD Million)
Global Non-invasive DNA Prenatal Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Non-invasive DNA Prenatal Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global Non-invasive DNA Prenatal Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Non-invasive DNA Prenatal Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Myriad Genetics, GGA, Fulgent Genetics, BillionToOne, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Non-invasive DNA Prenatal Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-invasive DNA Prenatal Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Core Condition Screening
- Expanded Condition Screening
- Whole Genome Sequencing
- Targeted Sequencing
- Others
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
1. How big is the global Non-invasive DNA Prenatal Testing market?
2. What is the demand of the global Non-invasive DNA Prenatal Testing market?
3. What is the year over year growth of the global Non-invasive DNA Prenatal Testing market?
4. What is the total value of the global Non-invasive DNA Prenatal Testing market?
5. Who are the Major Players in the global Non-invasive DNA Prenatal Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-invasive DNA Prenatal Testing Introduction
1.2 World Non-invasive DNA Prenatal Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Non-invasive DNA Prenatal Testing Total Market by Region (by Headquarter Location)
1.3.1 World Non-invasive DNA Prenatal Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.3 China Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.4 Europe Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.5 Japan Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.6 South Korea Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.8 India Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-invasive DNA Prenatal Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.2 World Non-invasive DNA Prenatal Testing Consumption Value by Region
2.2.1 World Non-invasive DNA Prenatal Testing Consumption Value by Region (2021-2026)
2.2.2 World Non-invasive DNA Prenatal Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.4 China Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.5 Europe Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.6 Japan Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.7 South Korea Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.8 ASEAN Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.9 India Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
3 WORLD NON-INVASIVE DNA PRENATAL TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-invasive DNA Prenatal Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-invasive DNA Prenatal Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for Non-invasive DNA Prenatal Testing in 2025
3.3 Non-invasive DNA Prenatal Testing Company Evaluation Quadrant
3.4 Non-invasive DNA Prenatal Testing Market: Overall Company Footprint Analysis
3.4.1 Non-invasive DNA Prenatal Testing Market: Region Footprint
3.4.2 Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
3.4.3 Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-invasive DNA Prenatal Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-invasive DNA Prenatal Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Non-invasive DNA Prenatal Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Non-invasive DNA Prenatal Testing Consumption Value Comparison
4.2.1 United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Non-invasive DNA Prenatal Testing Companies and Market Share, 2021-2026
4.3.1 United States Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026)
4.4 China Based Companies Non-invasive DNA Prenatal Testing Revenue and Market Share, 2021-2026
4.4.1 China Based Non-invasive DNA Prenatal Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026)
4.5 Rest of World Based Non-invasive DNA Prenatal Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Non-invasive DNA Prenatal Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Core Condition Screening
5.2.2 Expanded Condition Screening
5.3 Market Segment by Type
5.3.1 World Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
5.3.2 World Non-invasive DNA Prenatal Testing Market Size by Type (2027-2032)
5.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SEQUENCING METHOD
6.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Sequencing Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sequencing Method
6.2.1 Whole Genome Sequencing
6.2.2 Targeted Sequencing
6.2.3 Others
6.3 Market Segment by Sequencing Method
6.3.1 World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2021-2026)
6.3.2 World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2027-2032)
6.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Non-invasive DNA Prenatal Testing Market Size by Service Model (2021-2026)
7.3.2 World Non-invasive DNA Prenatal Testing Market Size by Service Model (2027-2032)
7.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
8.3.2 World Non-invasive DNA Prenatal Testing Market Size by Application (2027-2032)
8.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Natera
9.1.1 Natera Details
9.1.2 Natera Major Business
9.1.3 Natera Non-invasive DNA Prenatal Testing Product and Services
9.1.4 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Natera Recent Developments/Updates
9.1.6 Natera Competitive Strengths & Weaknesses
9.2 Labcorp
9.2.1 Labcorp Details
9.2.2 Labcorp Major Business
9.2.3 Labcorp Non-invasive DNA Prenatal Testing Product and Services
9.2.4 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Labcorp Recent Developments/Updates
9.2.6 Labcorp Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Non-invasive DNA Prenatal Testing Product and Services
9.3.4 Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Non-invasive DNA Prenatal Testing Product and Services
9.4.4 MedGenome Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product and Services
9.5.4 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 SYNLAB
9.6.1 SYNLAB Details
9.6.2 SYNLAB Major Business
9.6.3 SYNLAB Non-invasive DNA Prenatal Testing Product and Services
9.6.4 SYNLAB Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SYNLAB Recent Developments/Updates
9.6.6 SYNLAB Competitive Strengths & Weaknesses
9.7 Myriad Genetics
9.7.1 Myriad Genetics Details
9.7.2 Myriad Genetics Major Business
9.7.3 Myriad Genetics Non-invasive DNA Prenatal Testing Product and Services
9.7.4 Myriad Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Myriad Genetics Recent Developments/Updates
9.7.6 Myriad Genetics Competitive Strengths & Weaknesses
9.8 GGA
9.8.1 GGA Details
9.8.2 GGA Major Business
9.8.3 GGA Non-invasive DNA Prenatal Testing Product and Services
9.8.4 GGA Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 GGA Recent Developments/Updates
9.8.6 GGA Competitive Strengths & Weaknesses
9.9 Fulgent Genetics
9.9.1 Fulgent Genetics Details
9.9.2 Fulgent Genetics Major Business
9.9.3 Fulgent Genetics Non-invasive DNA Prenatal Testing Product and Services
9.9.4 Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Fulgent Genetics Recent Developments/Updates
9.9.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.10 BillionToOne
9.10.1 BillionToOne Details
9.10.2 BillionToOne Major Business
9.10.3 BillionToOne Non-invasive DNA Prenatal Testing Product and Services
9.10.4 BillionToOne Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BillionToOne Recent Developments/Updates
9.10.6 BillionToOne Competitive Strengths & Weaknesses
9.11 BGI Genomics
9.11.1 BGI Genomics Details
9.11.2 BGI Genomics Major Business
9.11.3 BGI Genomics Non-invasive DNA Prenatal Testing Product and Services
9.11.4 BGI Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BGI Genomics Recent Developments/Updates
9.11.6 BGI Genomics Competitive Strengths & Weaknesses
9.12 Berry Genomics
9.12.1 Berry Genomics Details
9.12.2 Berry Genomics Major Business
9.12.3 Berry Genomics Non-invasive DNA Prenatal Testing Product and Services
9.12.4 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Berry Genomics Recent Developments/Updates
9.12.6 Berry Genomics Competitive Strengths & Weaknesses
9.13 Annaroad
9.13.1 Annaroad Details
9.13.2 Annaroad Major Business
9.13.3 Annaroad Non-invasive DNA Prenatal Testing Product and Services
9.13.4 Annaroad Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Annaroad Recent Developments/Updates
9.13.6 Annaroad Competitive Strengths & Weaknesses
9.14 Genesky
9.14.1 Genesky Details
9.14.2 Genesky Major Business
9.14.3 Genesky Non-invasive DNA Prenatal Testing Product and Services
9.14.4 Genesky Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Genesky Recent Developments/Updates
9.14.6 Genesky Competitive Strengths & Weaknesses
9.15 Weihansi Biomedical Technology
9.15.1 Weihansi Biomedical Technology Details
9.15.2 Weihansi Biomedical Technology Major Business
9.15.3 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product and Services
9.15.4 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Weihansi Biomedical Technology Recent Developments/Updates
9.15.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Non-invasive DNA Prenatal Testing Industry Chain
10.2 Non-invasive DNA Prenatal Testing Upstream Analysis
10.3 Non-invasive DNA Prenatal Testing Midstream Analysis
10.4 Non-invasive DNA Prenatal Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Non-invasive DNA Prenatal Testing Introduction
1.2 World Non-invasive DNA Prenatal Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Non-invasive DNA Prenatal Testing Total Market by Region (by Headquarter Location)
1.3.1 World Non-invasive DNA Prenatal Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.3 China Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.4 Europe Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.5 Japan Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.6 South Korea Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.3.8 India Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-invasive DNA Prenatal Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.2 World Non-invasive DNA Prenatal Testing Consumption Value by Region
2.2.1 World Non-invasive DNA Prenatal Testing Consumption Value by Region (2021-2026)
2.2.2 World Non-invasive DNA Prenatal Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.4 China Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.5 Europe Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.6 Japan Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.7 South Korea Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.8 ASEAN Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
2.9 India Non-invasive DNA Prenatal Testing Consumption Value (2021-2032)
3 WORLD NON-INVASIVE DNA PRENATAL TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-invasive DNA Prenatal Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-invasive DNA Prenatal Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for Non-invasive DNA Prenatal Testing in 2025
3.3 Non-invasive DNA Prenatal Testing Company Evaluation Quadrant
3.4 Non-invasive DNA Prenatal Testing Market: Overall Company Footprint Analysis
3.4.1 Non-invasive DNA Prenatal Testing Market: Region Footprint
3.4.2 Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
3.4.3 Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-invasive DNA Prenatal Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-invasive DNA Prenatal Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Non-invasive DNA Prenatal Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Non-invasive DNA Prenatal Testing Consumption Value Comparison
4.2.1 United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Non-invasive DNA Prenatal Testing Companies and Market Share, 2021-2026
4.3.1 United States Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026)
4.4 China Based Companies Non-invasive DNA Prenatal Testing Revenue and Market Share, 2021-2026
4.4.1 China Based Non-invasive DNA Prenatal Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026)
4.5 Rest of World Based Non-invasive DNA Prenatal Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Non-invasive DNA Prenatal Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Core Condition Screening
5.2.2 Expanded Condition Screening
5.3 Market Segment by Type
5.3.1 World Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
5.3.2 World Non-invasive DNA Prenatal Testing Market Size by Type (2027-2032)
5.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SEQUENCING METHOD
6.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Sequencing Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sequencing Method
6.2.1 Whole Genome Sequencing
6.2.2 Targeted Sequencing
6.2.3 Others
6.3 Market Segment by Sequencing Method
6.3.1 World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2021-2026)
6.3.2 World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2027-2032)
6.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Non-invasive DNA Prenatal Testing Market Size by Service Model (2021-2026)
7.3.2 World Non-invasive DNA Prenatal Testing Market Size by Service Model (2027-2032)
7.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
8.3.2 World Non-invasive DNA Prenatal Testing Market Size by Application (2027-2032)
8.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Natera
9.1.1 Natera Details
9.1.2 Natera Major Business
9.1.3 Natera Non-invasive DNA Prenatal Testing Product and Services
9.1.4 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Natera Recent Developments/Updates
9.1.6 Natera Competitive Strengths & Weaknesses
9.2 Labcorp
9.2.1 Labcorp Details
9.2.2 Labcorp Major Business
9.2.3 Labcorp Non-invasive DNA Prenatal Testing Product and Services
9.2.4 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Labcorp Recent Developments/Updates
9.2.6 Labcorp Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Non-invasive DNA Prenatal Testing Product and Services
9.3.4 Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Non-invasive DNA Prenatal Testing Product and Services
9.4.4 MedGenome Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product and Services
9.5.4 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 SYNLAB
9.6.1 SYNLAB Details
9.6.2 SYNLAB Major Business
9.6.3 SYNLAB Non-invasive DNA Prenatal Testing Product and Services
9.6.4 SYNLAB Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SYNLAB Recent Developments/Updates
9.6.6 SYNLAB Competitive Strengths & Weaknesses
9.7 Myriad Genetics
9.7.1 Myriad Genetics Details
9.7.2 Myriad Genetics Major Business
9.7.3 Myriad Genetics Non-invasive DNA Prenatal Testing Product and Services
9.7.4 Myriad Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Myriad Genetics Recent Developments/Updates
9.7.6 Myriad Genetics Competitive Strengths & Weaknesses
9.8 GGA
9.8.1 GGA Details
9.8.2 GGA Major Business
9.8.3 GGA Non-invasive DNA Prenatal Testing Product and Services
9.8.4 GGA Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 GGA Recent Developments/Updates
9.8.6 GGA Competitive Strengths & Weaknesses
9.9 Fulgent Genetics
9.9.1 Fulgent Genetics Details
9.9.2 Fulgent Genetics Major Business
9.9.3 Fulgent Genetics Non-invasive DNA Prenatal Testing Product and Services
9.9.4 Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Fulgent Genetics Recent Developments/Updates
9.9.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.10 BillionToOne
9.10.1 BillionToOne Details
9.10.2 BillionToOne Major Business
9.10.3 BillionToOne Non-invasive DNA Prenatal Testing Product and Services
9.10.4 BillionToOne Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BillionToOne Recent Developments/Updates
9.10.6 BillionToOne Competitive Strengths & Weaknesses
9.11 BGI Genomics
9.11.1 BGI Genomics Details
9.11.2 BGI Genomics Major Business
9.11.3 BGI Genomics Non-invasive DNA Prenatal Testing Product and Services
9.11.4 BGI Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BGI Genomics Recent Developments/Updates
9.11.6 BGI Genomics Competitive Strengths & Weaknesses
9.12 Berry Genomics
9.12.1 Berry Genomics Details
9.12.2 Berry Genomics Major Business
9.12.3 Berry Genomics Non-invasive DNA Prenatal Testing Product and Services
9.12.4 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Berry Genomics Recent Developments/Updates
9.12.6 Berry Genomics Competitive Strengths & Weaknesses
9.13 Annaroad
9.13.1 Annaroad Details
9.13.2 Annaroad Major Business
9.13.3 Annaroad Non-invasive DNA Prenatal Testing Product and Services
9.13.4 Annaroad Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Annaroad Recent Developments/Updates
9.13.6 Annaroad Competitive Strengths & Weaknesses
9.14 Genesky
9.14.1 Genesky Details
9.14.2 Genesky Major Business
9.14.3 Genesky Non-invasive DNA Prenatal Testing Product and Services
9.14.4 Genesky Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Genesky Recent Developments/Updates
9.14.6 Genesky Competitive Strengths & Weaknesses
9.15 Weihansi Biomedical Technology
9.15.1 Weihansi Biomedical Technology Details
9.15.2 Weihansi Biomedical Technology Major Business
9.15.3 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product and Services
9.15.4 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Weihansi Biomedical Technology Recent Developments/Updates
9.15.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Non-invasive DNA Prenatal Testing Industry Chain
10.2 Non-invasive DNA Prenatal Testing Upstream Analysis
10.3 Non-invasive DNA Prenatal Testing Midstream Analysis
10.4 Non-invasive DNA Prenatal Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Non-invasive DNA Prenatal Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Non-invasive DNA Prenatal Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Non-invasive DNA Prenatal Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-invasive DNA Prenatal Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Non-invasive DNA Prenatal Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Non-invasive DNA Prenatal Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Non-invasive DNA Prenatal Testing Players in 2025
Table 12. World Non-invasive DNA Prenatal Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Non-invasive DNA Prenatal Testing Company Evaluation Quadrant
Table 14. Head Office of Key Non-invasive DNA Prenatal Testing Players
Table 15. Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
Table 16. Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
Table 17. Non-invasive DNA Prenatal Testing Mergers & Acquisitions Activity
Table 18. United States VS China Non-invasive DNA Prenatal Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Non-invasive DNA Prenatal Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2021-2026)
Table 23. China Based Non-invasive DNA Prenatal Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Non-invasive DNA Prenatal Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2021-2026)
Table 29. World Non-invasive DNA Prenatal Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Non-invasive DNA Prenatal Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Non-invasive DNA Prenatal Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Non-invasive DNA Prenatal Testing Market Size Value by Sequencing Method (2021-2026) & (USD Million)
Table 34. World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2027-2032) & (USD Million)
Table 35. World Non-invasive DNA Prenatal Testing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Non-invasive DNA Prenatal Testing Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Non-invasive DNA Prenatal Testing Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Non-invasive DNA Prenatal Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Non-invasive DNA Prenatal Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. Natera Basic Information, Manufacturing Base and Competitors
Table 42. Natera Major Business
Table 43. Natera Non-invasive DNA Prenatal Testing Product and Services
Table 44. Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Manufacturing Base and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Non-invasive DNA Prenatal Testing Product and Services
Table 50. Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Non-invasive DNA Prenatal Testing Product and Services
Table 56. Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Non-invasive DNA Prenatal Testing Product and Services
Table 62. MedGenome Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product and Services
Table 68. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 72. SYNLAB Major Business
Table 73. SYNLAB Non-invasive DNA Prenatal Testing Product and Services
Table 74. SYNLAB Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SYNLAB Recent Developments/Updates
Table 76. SYNLAB Competitive Strengths & Weaknesses
Table 77. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 78. Myriad Genetics Major Business
Table 79. Myriad Genetics Non-invasive DNA Prenatal Testing Product and Services
Table 80. Myriad Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Myriad Genetics Recent Developments/Updates
Table 82. Myriad Genetics Competitive Strengths & Weaknesses
Table 83. GGA Basic Information, Manufacturing Base and Competitors
Table 84. GGA Major Business
Table 85. GGA Non-invasive DNA Prenatal Testing Product and Services
Table 86. GGA Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GGA Recent Developments/Updates
Table 88. GGA Competitive Strengths & Weaknesses
Table 89. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Fulgent Genetics Major Business
Table 91. Fulgent Genetics Non-invasive DNA Prenatal Testing Product and Services
Table 92. Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Fulgent Genetics Recent Developments/Updates
Table 94. Fulgent Genetics Competitive Strengths & Weaknesses
Table 95. BillionToOne Basic Information, Manufacturing Base and Competitors
Table 96. BillionToOne Major Business
Table 97. BillionToOne Non-invasive DNA Prenatal Testing Product and Services
Table 98. BillionToOne Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BillionToOne Recent Developments/Updates
Table 100. BillionToOne Competitive Strengths & Weaknesses
Table 101. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 102. BGI Genomics Major Business
Table 103. BGI Genomics Non-invasive DNA Prenatal Testing Product and Services
Table 104. BGI Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BGI Genomics Recent Developments/Updates
Table 106. BGI Genomics Competitive Strengths & Weaknesses
Table 107. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Berry Genomics Major Business
Table 109. Berry Genomics Non-invasive DNA Prenatal Testing Product and Services
Table 110. Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Berry Genomics Recent Developments/Updates
Table 112. Berry Genomics Competitive Strengths & Weaknesses
Table 113. Annaroad Basic Information, Manufacturing Base and Competitors
Table 114. Annaroad Major Business
Table 115. Annaroad Non-invasive DNA Prenatal Testing Product and Services
Table 116. Annaroad Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Annaroad Recent Developments/Updates
Table 118. Annaroad Competitive Strengths & Weaknesses
Table 119. Genesky Basic Information, Manufacturing Base and Competitors
Table 120. Genesky Major Business
Table 121. Genesky Non-invasive DNA Prenatal Testing Product and Services
Table 122. Genesky Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Genesky Recent Developments/Updates
Table 124. Genesky Competitive Strengths & Weaknesses
Table 125. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 126. Weihansi Biomedical Technology Major Business
Table 127. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product and Services
Table 128. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Weihansi Biomedical Technology Recent Developments/Updates
Table 130. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 131. Global Key Players of Non-invasive DNA Prenatal Testing Upstream (Raw Materials)
Table 132. Global Non-invasive DNA Prenatal Testing Typical Customers
Table 1. World Non-invasive DNA Prenatal Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Non-invasive DNA Prenatal Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Non-invasive DNA Prenatal Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-invasive DNA Prenatal Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Non-invasive DNA Prenatal Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Non-invasive DNA Prenatal Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Non-invasive DNA Prenatal Testing Players in 2025
Table 12. World Non-invasive DNA Prenatal Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Non-invasive DNA Prenatal Testing Company Evaluation Quadrant
Table 14. Head Office of Key Non-invasive DNA Prenatal Testing Players
Table 15. Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
Table 16. Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
Table 17. Non-invasive DNA Prenatal Testing Mergers & Acquisitions Activity
Table 18. United States VS China Non-invasive DNA Prenatal Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Non-invasive DNA Prenatal Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2021-2026)
Table 23. China Based Non-invasive DNA Prenatal Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-invasive DNA Prenatal Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Non-invasive DNA Prenatal Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2021-2026)
Table 29. World Non-invasive DNA Prenatal Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Non-invasive DNA Prenatal Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Non-invasive DNA Prenatal Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Non-invasive DNA Prenatal Testing Market Size Value by Sequencing Method (2021-2026) & (USD Million)
Table 34. World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2027-2032) & (USD Million)
Table 35. World Non-invasive DNA Prenatal Testing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Non-invasive DNA Prenatal Testing Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Non-invasive DNA Prenatal Testing Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Non-invasive DNA Prenatal Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Non-invasive DNA Prenatal Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. Natera Basic Information, Manufacturing Base and Competitors
Table 42. Natera Major Business
Table 43. Natera Non-invasive DNA Prenatal Testing Product and Services
Table 44. Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Manufacturing Base and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Non-invasive DNA Prenatal Testing Product and Services
Table 50. Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Non-invasive DNA Prenatal Testing Product and Services
Table 56. Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Non-invasive DNA Prenatal Testing Product and Services
Table 62. MedGenome Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product and Services
Table 68. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 72. SYNLAB Major Business
Table 73. SYNLAB Non-invasive DNA Prenatal Testing Product and Services
Table 74. SYNLAB Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SYNLAB Recent Developments/Updates
Table 76. SYNLAB Competitive Strengths & Weaknesses
Table 77. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 78. Myriad Genetics Major Business
Table 79. Myriad Genetics Non-invasive DNA Prenatal Testing Product and Services
Table 80. Myriad Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Myriad Genetics Recent Developments/Updates
Table 82. Myriad Genetics Competitive Strengths & Weaknesses
Table 83. GGA Basic Information, Manufacturing Base and Competitors
Table 84. GGA Major Business
Table 85. GGA Non-invasive DNA Prenatal Testing Product and Services
Table 86. GGA Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GGA Recent Developments/Updates
Table 88. GGA Competitive Strengths & Weaknesses
Table 89. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Fulgent Genetics Major Business
Table 91. Fulgent Genetics Non-invasive DNA Prenatal Testing Product and Services
Table 92. Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Fulgent Genetics Recent Developments/Updates
Table 94. Fulgent Genetics Competitive Strengths & Weaknesses
Table 95. BillionToOne Basic Information, Manufacturing Base and Competitors
Table 96. BillionToOne Major Business
Table 97. BillionToOne Non-invasive DNA Prenatal Testing Product and Services
Table 98. BillionToOne Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BillionToOne Recent Developments/Updates
Table 100. BillionToOne Competitive Strengths & Weaknesses
Table 101. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 102. BGI Genomics Major Business
Table 103. BGI Genomics Non-invasive DNA Prenatal Testing Product and Services
Table 104. BGI Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BGI Genomics Recent Developments/Updates
Table 106. BGI Genomics Competitive Strengths & Weaknesses
Table 107. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Berry Genomics Major Business
Table 109. Berry Genomics Non-invasive DNA Prenatal Testing Product and Services
Table 110. Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Berry Genomics Recent Developments/Updates
Table 112. Berry Genomics Competitive Strengths & Weaknesses
Table 113. Annaroad Basic Information, Manufacturing Base and Competitors
Table 114. Annaroad Major Business
Table 115. Annaroad Non-invasive DNA Prenatal Testing Product and Services
Table 116. Annaroad Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Annaroad Recent Developments/Updates
Table 118. Annaroad Competitive Strengths & Weaknesses
Table 119. Genesky Basic Information, Manufacturing Base and Competitors
Table 120. Genesky Major Business
Table 121. Genesky Non-invasive DNA Prenatal Testing Product and Services
Table 122. Genesky Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Genesky Recent Developments/Updates
Table 124. Genesky Competitive Strengths & Weaknesses
Table 125. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 126. Weihansi Biomedical Technology Major Business
Table 127. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product and Services
Table 128. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Weihansi Biomedical Technology Recent Developments/Updates
Table 130. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 131. Global Key Players of Non-invasive DNA Prenatal Testing Upstream (Raw Materials)
Table 132. Global Non-invasive DNA Prenatal Testing Typical Customers
LIST OF FIGURES
Figure 1. Non-invasive DNA Prenatal Testing Picture
Figure 2. World Non-invasive DNA Prenatal Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-invasive DNA Prenatal Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Non-invasive DNA Prenatal Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 13. Non-invasive DNA Prenatal Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Non-invasive DNA Prenatal Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-invasive DNA Prenatal Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-invasive DNA Prenatal Testing Markets in 2025
Figure 27. United States VS China: Non-invasive DNA Prenatal Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Non-invasive DNA Prenatal Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Non-invasive DNA Prenatal Testing Market Size Market Share by Type in 2025
Figure 31. Core Condition Screening
Figure 32. Expanded Condition Screening
Figure 33. World Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2032)
Figure 34. World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Figure 35. World Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method in 2025
Figure 36. Whole Genome Sequencing
Figure 37. Targeted Sequencing
Figure 38. Others
Figure 39. World Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2021-2032)
Figure 40. World Non-invasive DNA Prenatal Testing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 41. World Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model in 2025
Figure 42. Public Health Program
Figure 43. Consumer
Figure 44. Others
Figure 45. World Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2021-2032)
Figure 46. World Non-invasive DNA Prenatal Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Non-invasive DNA Prenatal Testing Market Size Market Share by Application in 2025
Figure 48. Public Hospitals
Figure 49. Private Hospitals
Figure 50. World Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2032)
Figure 51. Non-invasive DNA Prenatal Testing Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Non-invasive DNA Prenatal Testing Picture
Figure 2. World Non-invasive DNA Prenatal Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-invasive DNA Prenatal Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Non-invasive DNA Prenatal Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Non-invasive DNA Prenatal Testing Revenue (2021-2032) & (USD Million)
Figure 13. Non-invasive DNA Prenatal Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Non-invasive DNA Prenatal Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Non-invasive DNA Prenatal Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-invasive DNA Prenatal Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-invasive DNA Prenatal Testing Markets in 2025
Figure 27. United States VS China: Non-invasive DNA Prenatal Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Non-invasive DNA Prenatal Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Non-invasive DNA Prenatal Testing Market Size Market Share by Type in 2025
Figure 31. Core Condition Screening
Figure 32. Expanded Condition Screening
Figure 33. World Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2032)
Figure 34. World Non-invasive DNA Prenatal Testing Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Figure 35. World Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method in 2025
Figure 36. Whole Genome Sequencing
Figure 37. Targeted Sequencing
Figure 38. Others
Figure 39. World Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2021-2032)
Figure 40. World Non-invasive DNA Prenatal Testing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 41. World Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model in 2025
Figure 42. Public Health Program
Figure 43. Consumer
Figure 44. Others
Figure 45. World Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2021-2032)
Figure 46. World Non-invasive DNA Prenatal Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Non-invasive DNA Prenatal Testing Market Size Market Share by Application in 2025
Figure 48. Public Hospitals
Figure 49. Private Hospitals
Figure 50. World Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2032)
Figure 51. Non-invasive DNA Prenatal Testing Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
